MedPath

studying the effect of botox on hormonal female hair loss

Phase 2
Recruiting
Conditions
androgenetic alopecia.
Androgenic alopecia
Registration Number
IRCT20221016056203N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
63
Inclusion Criteria

Patients with grade 2/4/3 based on SINCLAIR SCALE for disease severity
having the ability for regular visits
Not receiving previous treatment in the last three months
age between 18-55
not having contraindication for minoxidil 5% and botulinum toxin

Exclusion Criteria

Having needle phobia
Having alopecia areata and another hair diseases(LPP)
Having neuromuscular disease
Previous use of corticosteroids or immunosuppressive drugrs in the last 3 months
Having localized infection
Having internal systemic and skin disease or localized dermatosis.
Patients with a history of bleeding diseases or under treatment with anticoagulants
Previous family or personal history of keloid
Having koebner phenomenon
Having symptoms of hyperandrogenism and in need for systemic drugs
pregnancy and lactation
Another treatments in less than 3 months.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hair volume and density in qualitative and quantitative way. Timepoint: 3 and 6 months after starting treatment. Method of measurement: photography - photo finder - dermoscopy -self assessment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath